naltrexone has been researched along with Hepatitis C in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Paola, A; Lier, AJ; Seval, N; Springer, SA; Vander Wyk, B | 1 |
| Alam, F; Dhadley, S; Roberts, P; Townley, J; Webster, R; Wright, N | 1 |
| Harlos, MS; Hohl, CM; Wong, JK | 1 |
| Kampman, KM; Oslin, DW; Pettinati, HM; Plebani, JG; Tirado, CF; Volpicelli, JR | 1 |
| Brewer, C; Wong, VS | 1 |
| Dore, GJ | 1 |
| Bull, J; Chua, F; Galhenage, S; Hulse, G; Jeffrey, GP; MacQuillan, G; O'Neil, G; Young, E | 1 |
| Kreek, MJ; Novick, DM | 1 |
| Gutiérrez Mora, E; Lozano Polo, JL; Martínez Pérez, V; Santamaría Gutiérrez, J; Vada Sánchez, J; Vallejo Correas, JA | 1 |
| Konlee, M | 1 |
1 review(s) available for naltrexone and Hepatitis C
| Article | Year |
|---|---|
Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature.
Topics: Acute Disease; Adult; Delayed-Action Preparations; Drug Implants; Hepatitis B; Hepatitis C; Heroin Dependence; Humans; Liver Function Tests; Male; Naltrexone; Narcotic Antagonists | 2004 |
4 trial(s) available for naltrexone and Hepatitis C
| Article | Year |
|---|---|
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Hepatitis C; HIV Infections; Humans; Injections, Intramuscular; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; RNA; Social Justice | 2022 |
Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence.
Topics: Adult; Alanine Transaminase; Alcoholism; Aspartate Aminotransferases; Cocaine-Related Disorders; Female; gamma-Glutamyltransferase; Hepatitis C; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Risk Factors; Risk-Taking; Transferrin | 2010 |
Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants.
Topics: Adolescent; Adult; Antiviral Agents; Drug Implants; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Compliance; Prospective Studies; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome | 2007 |
[Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection].
Topics: Adult; Female; Hepatitis C; Humans; Liver; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Necrosis; Prospective Studies; Substance Abuse, Intravenous; Transaminases | 1997 |
5 other study(ies) available for naltrexone and Hepatitis C
| Article | Year |
|---|---|
Optimising opioid substitution therapy in the prison environment.
Topics: Age Factors; Buprenorphine; Comorbidity; Continuity of Patient Care; Delayed-Action Preparations; Drug Administration Schedule; England; Hepatitis C; HIV Infections; Humans; Mental Disorders; Methadone; Naltrexone; Narcotics; Needle Sharing; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Quality Improvement; Social Work; Wales | 2019 |
Methylnaltrexone to Palliate Pruritus in Terminal Hepatic Disease.
Topics: Aged; Carcinoma, Hepatocellular; Fatal Outcome; Female; Gallbladder Neoplasms; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pain Measurement; Pruritus; Quaternary Ammonium Compounds; Terminal Care | 2015 |
Enhancing hepatitis C treatment uptake and outcomes for injection drug users.
Topics: Antiviral Agents; Hepatitis C; Humans; Interferons; Naltrexone; Narcotic Antagonists; Patient Compliance; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome | 2007 |
Hepatitis C treatment, subcutaneous naltrexone implants, and methadone maintenance treatment.
Topics: Antiviral Agents; Drug Implants; Hepatitis C; Humans; Methadone; Morphine Dependence; Naltrexone; Narcotics | 2007 |
New treatments for hepatitis B and C [antigen-specific transfer for A, B & C (chisolm biologicals) and thymate].
Topics: Blood Coagulation; Complementary Therapies; Dietary Supplements; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Humans; Naltrexone; Narcotic Antagonists; Plant Extracts; Thioctic Acid; Transfer Factor; Viral Load | 1998 |